Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2022, Vol. 36 ›› Issue (4): 6-11.doi: 10.6040/j.issn.1673-3770.0.2021.195
Previous Articles Next Articles
YANG Kun1, CHEN Lijuan2, HE Xiaodan3, LIU Zhiqi3, SHA Suhua4
CLC Number:
[1] Stogios PJ, Evdokimova E, Morar M, et al. Structural and functional plasticity of antibiotic resistance nucleotidylyltransferases revealed by molecular characterization of lincosamide nucleotidylyltransferases lnu(A)and lnu(D)[J]. J Mol Biol, 2015, 427(12): 2229-2243. doi:10.1016/j.jmb.2015.04.008. [2] Alobaidy H. Recent advances in the diagnosis and treatment of niemann-pick disease type C in children: a guide to early diagnosis for the general pediatrician[J]. Int J Pediatr, 2015, 2015: 816593. doi:10.1155/2015/816593. [3] Mengel E, Klünemann HH, Lourenço CM, et al. Niemann-Pick disease type C symptomatology: an expert-based clinical description[J]. Orphanet J Rare Dis, 2013, 8(1): 166. doi:10.1186/1750-1172-8-166. [4] Wu WJ, Sha SH, McLaren JD, et al. Aminoglycoside ototoxicity in adult CBA, C57BL and BALB mice and the Sprague-Dawley rat[J]. Hearing Research, 2001, 158:165-178. doi:10.1016/S0378-5955(01)00303-3. [5] Sarah W, Patricia OD, Steven F, et al. 2-hydroxypropyl-β-cyclodextrin raises hearing threshold in normal cats and in cats with Niemann-Pick type C disease[J]. Pediatr Res,2010, 68(1): 52-56. doi:10.1203/PDR.0b013e3181df4623. [6] Ory DS, Ottinger EA, Farhat, NY, et al. Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial[J]. Lancet, 2017, 390, 1758-1768. doi:10.1016/S0140-6736(17)31465-4. [7] Jiang MY, Karasawa T, Steyger PS. Aminoglycoside-induced cochleotoxicity: a review[J]. Front Cell Neurosci, 2017, 11: 308. doi:10.3389/fncel.2017.00308. [8] Davidson CD, Ali NF, Micsenyi MC, et al. Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression[J]. PLoS One, 2009, 4(9): e6951. doi:10.1371/journal.pone.0006951. [9] Liu B, Ramirez CM, Miller AM, et al. Cyclodextrin overcomes the transport defect in nearly every organ of NPC1 mice leading to excretion of sequestered cholesterol as bile acid[J]. J Lipid Res, 2010, 51(5): 933-944. doi:10.1194/jlr.M000257. [10] Kros CJ, Steyger PS. Aminoglycoside- and cisplatin-induced ototoxicity: mechanisms and otoprotective strategies[J]. Cold Spring Harb Perspect Med, 2019, 9(11): a033548. doi:10.1101/cshperspect.a033548. [11] Lee MY, Kabara LL, Swiderski DL, et al. ROS scavenger, ebselen, has no preventive effect in new hearing loss model using a cholesterol-chelating agent[J]. J Audiol Otol, 2019, 23(2): 69-75. doi:10.7874/jao.2018.00255. |
[1] | WANG Xiao1, JU Hong-shuang2, LIANG Gui-ling1, YAN Yong-hong1, SU Mei1. FK506 as antagonist to ototoxicity of Gentamycin [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2010, 24(6): 13-16. |
|